Upcoming events

May 30, 2022 Providence Pulse Content Team

Share this Article
Facebook
Twitter
LinkedIn

Providence Virtual Pediatric Grand Rounds: Healthy Kids Together: Let 5210+9 Be Your Guide
12:30 – 1:15 p.m., June 15, 2022

Carla McKelvey, M.D., and Providence Children’s Health invite you to a virtual educational offering with pediatrician Jacob Sheff and pediatric psychologist Tyson Payne who review the evidence-based 5210+9 guidelines as a tool for keeping children healthy. Drs. Sheff and Payne help us identify those most at risk and help us better understand each component of the 5210+9 guidelines.

Participation with CME is free to everyone. The event is hosted over Microsoft Teams; access information is shared upon registration.

About the Author

The Pulse content team focuses on bringing you the latest in clinical news from our world-class medical providers and physician leaders.
More Content by Providence Pulse Content Team

People of Providence

Improving treatment and quality of life for patients with colorectal cancer

Both the U.S. Preventive Services Task Force and the American Cancer Society now recommend colorectal cance...

Most Recent Articles

Get your flu shot Sept. 25 – Oct. 31: three easy options for medical staff

Upcoming events

About the Author

Previous Article

Next Article

Most Recent Articles

Projections indicate this will be a substantial influenza season that occurs earlier than in prior years. The good news is this year’s influenza vaccine effectiveness is considered to be strong.

A new clinical trial at Providence Cancer Institute of Oregon is evaluating an immunotherapy viral vector vaccine targeting both prostate specific antigen (PSA) and prostatic acid phosphatase (PAP).

Jamal’s prior negative experiences with health care made him distrustful. When his wife Amy was diagnosed with Alzheimer’s disease in her late 60s, their world changed, and they needed help.

Congratulations to Providence Portland Medical Center for being designated an Aetna Institute of Quality® Bariatric Surgery Facility for treating patients living with morbid, or extreme, obesity.

Due to shifts in staffing, Providence Oregon’s clinician newsletters will undergo changes to its two main publications, Pulse and InScope.

Providence Cancer Institute recently held its annual fundraising event, Creating Hope, which has raised $12.6 million for cancer research during the past 25 years.

Patients at Providence Cancer Institute of Oregon can receive integrative medicine services to help manage the side effects of treatment and support their emotional and spiritual well-being.

Generous supporters donated $51 million to Providence Oregon in 2022, funding scientific and clinical discoveries, programs, equipment and services that help your patients live longer, healthier lives

Providence Oregon providers are encouraged to read this quarterly wellness newsletter sponsored by the Oregon Medical Executive Committee’s Professional Staff Wellness Subcommittee.

Thanks to an innovative wellness pilot program, hospitalists at Providence Portland Medical Center experienced a 32% burnout rate compared to the control group’s 56%.

The Providence Head and Neck Cancer Program offers patients the latest therapies, surgical approaches and oral oncology care to help minimize and manage the side effects of cancer and cancer treatment

During the past three years, we’ve seen many manifestations and complications related to COVID-19.

The Providence Cancer Institute Willamette Falls Clinic, located within the new Carol D. Suzuki Cancer Center, opened March 20.

After three years of planning, Providence St. Vincent Medical Center is transforming our 30-year-old emergency department to better meet the needs of our growing community.

A new survey tool, called the Well-being Index, is available Jan. 19 through Feb. 16 and will provide both individual and organizational feedback on the well-being of Providence Oregon’s providers.

The Immuno-oncology Research Fellowship is an opportunity for medical professionals to develop an expertise in clinical immunotherapies for treating cancer and more.